PACTR201612001901313已完成未知
Effectiveness of the combination of dihydroartemisinin and piperaquine for prevention of falciparum malaria during pregnancy in Tanzania
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- MUHAS
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 Year(s) 至 35 Year(s)（—）
- 性别
- Female
入选标准
- •i.Viable pregnancy assessed by UPT
- •ii.Gestational age 16 to 32 weeks (inclusive) determined by fundal height
- •iii. No prior history of IPTp use for current pregnancy
- •iv.Willing to participate and complete the study schedule
- •v.Willing to sign or thumb print informed consent
- •vi. Resident of study area and intending to stay in the area for the duration of the follow-up
- •vii.Willing to deliver at the health facility
排除标准
- •i.Residence outside study area or planning to move out in the 12 months following enrolment
- •ii.High risk pregnancy, including any pre-existing illness likely to cause complication of pregnancy (hypertension, diabetes, asthma, epilepsy, renal disease, liver disease, fistula repair, leg or spine deformity)
- •iii.Severe anemia requiring blood transfusion (Hb ¿ 7.0 g/dL) at enrolment
- •iv.Known allergy or previous adverse reaction to any of the study drugs
- •v.Unable to give informed consent (for example due to mental disability)
- •vi.Previous inclusion in the same study
研究者
相似试验
已完成
4 期
Efficacy and safety of the combination dihydroartemisinin-piperaquine (DHA-PIP) for the treatment of uncomplicated Plasmodium falciparum malaria in Champasack province, Laos PDRInfection - Studies of infection and infectious agentsMalariaACTRN12618001650280Ministry of Health100
已完成
不适用
Efficacy and safety of artesunate and dihydroartemisinin-piparaquine (DHA-PIP) for the treatment of uncomplicated Plasmodium falciparum malaria and chloroquine in Plasmodium vivax malaria in Yunnan and Jiangsu province, ChinaInfection - Other infectious diseasesMalariaACTRN12610001008011ational Institute of Parasitic Diseases, China Center for Disease Control and Prevention240
招募中
4 期
Efficacy and safety of artesunate and dihydroartemisinin-piperaquine tablets for the treatment of uncomplicated Plasmodium falciparum malaria and Chloroquine for the treatment of Plasmodium vivax malaria in Bu Dang of Binh Phuoc, Tuy Duc of Dak Nong, Huong Hoa of Quang Tri and Gia Lai provinces, Viet Nam in 2010Infection - Studies of infection and infectious agentsMalariaACTRN12611000175976Ministry of Health200
进行中（未招募）
不适用
Efficacy and safety of artesunate and dihydroartemisinin-piparaquine (DHA-PIP) for the treatment of uncomplicated Plasmodium falciparum malaria in Yunnan, ChinamalariaACTRN12610001028099ational Institute of Parasitic Diseases, China Center for Disease Control and Prevention120
尚未招募
4 期
Efficacy and safety of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in 6 sentinel sites in IndonesiaInfection - Studies of infection and infectious agentsMalariaACTRN12614000753651Ministry of Health1,200